Citation Impact
Citing Papers
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
FRAX™ and the assessment of fracture probability in men and women from the UK
2008 Standout
Energy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy – a longitudinal study
2005
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Bone Mineral Density Testing in Healthy Postmenopausal Women
2002
EULAR recommendations for the management of primary small and medium vessel vasculitis
2008 Standout
Child abuse: Adolescent records vs. adult recall
1990 Standout
Health benefits of physical activity: the evidence
2006 Standout
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Chronic Glucocorticoid Therapy-Induced Osteoporosis in Patients With Obstructive Lung Disease
1999
Osteoporosis
2019 Standout
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Management of osteoporosis
2004
The Impact of Severe Asthma on Schoolchildren
1999
Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and Calcitonin
1993
Recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
1996
Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis
2007
Oral corticosteroids and fracture risk: relationship to daily and cumulative doses
2000
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
2009 Standout
Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study
1996
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 Standout
Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler®
2002
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Cushing's syndrome
2015 Standout
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
2008 Standout
BONE LOSS AND FRACTURE AFTER LUNG TRANSPLANTATION1
1999
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
2010 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
2015 Standout
Nutrition and physical activity guidelines for cancer survivors
2012 Standout
The Epidemiology of Corticosteroid-Induced Osteoporosis: a Meta-analysis
2002
Vitamin D Deficiency
2007 Standout
Corticosteroids contribute to muscle weakness in chronic airflow obstruction.
1994
A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update
1998
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Osteoporosis: now and the future
2011 Standout
Glucocorticoid-induced Osteoporosis
2000
Skeletal remodeling in health and disease
2007 Standout
Risedronate therapy prevents corticosteroid-induced bone loss : A twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
1999
Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation
1998
Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids
2004
THE SCIENCE AND THERAPY OF GLUCOCORTICOID-INDUCED BONE LOSS
1998
Mechanisms involved in the side effects of glucocorticoids
2002 Standout
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
2006 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Inhaled and nasal corticosteroids Factors affecting the risks of systemic adverse effects
1999
Systemic Adverse Effects of Inhaled Corticosteroid Therapy
1999
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Prevalence of Reduced Bone Mineral Density in Patients with Anti-neutrophil Cytoplasmic Antibody Associated Vasculitis and the Role of Immunosuppressive Therapy: A Cross-Sectional Study
2002
Inhaled and Systemic Corticosteroid Therapies: Do They Contribute to Inspiratory Muscle Weakness in Asthma?
1999
Osteoporosis in Cushing�s Syndrome
2002
Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy
2003
What old means to bone
2010 Standout
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Potential Effects of Fluticasone Propionate on Bone Mineral Density in Patients With Asthma: A 2-Year Randomized, Double-Blind, Placebo-Controlled Trial
2004
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
2004 Standout
The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results
2000
Glucocorticoid-induced Osteoporosis: Prevention and Treatment
1998
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data
2005
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
2010
Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials
2003 Standout
Glucocorticoid-induced osteoporosis
2000
COPD and Osteoporosis
2002
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Impact of Nutritional Support on Functional Status During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
1997
Glucocorticoids Act Directly on Osteoblasts and Osteocytes to Induce Their Apoptosis and Reduce Bone Formation and Strength
2003
Testosterone Therapy in Glucocorticoid-Treated Men
1996
Disorders Associated With Acute Rapid and Severe Bone Loss
2003
Efficacy and Safety of Daily Risedronate in the Treatment of Corticosteroid-Induced Osteoporosis in Men and Women: A Randomized Trial
2000
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs.
2001
Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease
2002
Use of Oral Corticosteroids and Risk of Fractures
2000 Standout
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus
2005
The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003
2003 Standout
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Glucocorticoid Osteoporosis
1999
A Test of Pre–Main‐Sequence Evolutionary Models across the Stellar/Substellar Boundary Based on Spectra of the Young Quadruple GG Tauri
1999 StandoutNobel
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
Use of Inhaled Corticosteroids and Risk of Fractures
2001 Standout
Rheumatoid arthritis, corticosteroid therapy and hip fracture.
1995
Corticosteroids and Fractures: A Close Encounter of the Third Cell Kind
2000
Bone metabolism and disease in chronic kidney disease
2003
GLUCOCORTICOID-INDUCED OSTEOPOROSIS
1994
Works of M Luengo being referenced
Treatment of Steroid-induced Osteopenia with Calcitonin in Corticosteroid-dependent Asthma: A One-Year Follow-up Study
1990
Ability of Asthmatics with and Without Respiratory Arrest to Detect Added Resistive Loads
1988
Bone mineral density in asthmatic patients treated with inhaled corticosteroids: a case-control study
1997
Corticosteroid-Induced Bone Loss
1996
Respiratory and Skeletal Muscle Function in Steroid-dependent Bronchial Asthma
1990
Intestinal calcium absorption and parathyroid hormone secretion in asthmatic patients on prolonged oral or inhaled steroid treatment
1991
Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study.
1994
Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study.
1991